See more : X5 Retail Group N.V. (FIVE.IL) Income Statement Analysis – Financial Results
Complete financial analysis of CB Scientific, Inc. (CBSC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CB Scientific, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- AUCMA Co.,Ltd. (600336.SS) Income Statement Analysis – Financial Results
- PT Jakarta Kyoei Steel Works, Tbk (JKSW.JK) Income Statement Analysis – Financial Results
- ThinkSmart Limited (TSLMF) Income Statement Analysis – Financial Results
- Williams Industrial Services Group Inc. (WLMS) Income Statement Analysis – Financial Results
- SecureTech Innovations, Inc. (SCTH) Income Statement Analysis – Financial Results
CB Scientific, Inc. (CBSC)
About CB Scientific, Inc.
CB Scientific, Inc., through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally. Its EKG devices, interactive cloud-based acquisition software, and smartphone apps provide improved compliance for patients at risk of abnormal heart rhythms, as well as accurate information for physicians. The company is based in Escondido, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 135.06K | 82.41K | 75.58K | 32.44K | 121.93K | 58.67K | 36.61K | 32.95K |
| Cost of Revenue | 0.00 | 42.24K | 149.24K | 9.81K | 720.03K | 43.82K | 414.66K | 227.35K |
| Gross Profit | 135.06K | 40.17K | -73.67K | 22.63K | -598.10K | 14.85K | -378.05K | -194.40K |
| Gross Profit Ratio | 100.00% | 48.74% | -97.47% | 69.76% | -490.53% | 25.30% | -1,032.60% | -589.96% |
| Research & Development | 419.74K | 485.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.31M | 2.14M | 1.80M | 2.96M | 0.00 | 0.00 | 89.45 | 160.16 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 89.36K | 160.00K |
| SG&A | 1.31M | 2.14M | 1.80M | 2.96M | 318.42K | 77.41K | 89.45K | 160.16K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -82.93K | 0.00 | -13.90K | -15.20K |
| Operating Expenses | 1.73M | 2.14M | 1.80M | 2.97M | 401.35K | 77.41K | 103.35K | 175.36K |
| Cost & Expenses | 1.73M | 2.18M | 1.95M | 2.98M | 1.12M | 121.24K | 518.01K | 402.72K |
| Interest Income | 0.00 | 542.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.29K | 5.21K | 1.54M | 344.30K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -29.25K | 611.00 | 611.00 | 6.75K | 171.86K | 3.02K | 3.34K | 481.00 |
| EBITDA | -1.62M | -2.10M | -4.80M | -3.98M | -999.45K | -59.55K | -1.13M | -369.29K |
| EBITDA Ratio | -1,203.18% | -2,550.05% | -2,474.61% | -9,050.68% | -819.70% | -101.50% | -1,305.78% | -1,120.69% |
| Operating Income | -1.60M | -2.10M | -1.87M | -2.94M | -999.45K | -62.57K | -481.39K | -369.76K |
| Operating Income Ratio | -1,181.52% | -2,550.71% | -2,475.42% | -9,071.50% | -819.70% | -106.65% | -1,314.88% | -1,122.15% |
| Total Other Income/Expenses | -34.54K | -4.66K | -4.47M | -1.39M | 0.00 | 0.00 | -650.01K | -16.25K |
| Income Before Tax | -1.63M | -2.11M | -6.34M | -4.33M | -999.45K | -62.57K | -1.13M | -386.02K |
| Income Before Tax Ratio | -1,207.10% | -2,556.37% | -8,391.92% | -13,341.40% | -819.70% | -106.65% | -3,090.31% | -1,171.49% |
| Income Tax Expense | 0.00 | -227.94K | 1.54M | 344.30K | -171.86K | -4.00 | -5.00 | -1.00 |
| Net Income | -1.63M | -2.11M | -6.34M | -4.33M | -999.45K | -62.57K | -1.13M | -386.02K |
| Net Income Ratio | -1,207.10% | -2,556.37% | -8,391.92% | -13,341.40% | -819.70% | -106.65% | -3,090.31% | -1,171.49% |
| EPS | -0.01 | -0.02 | -0.07 | -0.06 | -0.02 | 0.00 | -0.02 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.07 | -0.06 | -0.02 | 0.00 | -0.02 | -0.01 |
| Weighted Avg Shares Out | 139.59M | 119.15M | 91.22M | 77.92M | 58.59M | 57.97M | 57.97M | 57.11M |
| Weighted Avg Shares Out (Dil) | 139.59M | 119.15M | 91.22M | 77.92M | 58.59M | 57.97M | 57.97M | 57.11M |
CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer
LAS VEGAS, NV / ACCESSWIRE / October 3, 2024 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, announced today that the Company's Board of Directors...
CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market
LAS VEGAS, NV / ACCESSWIRE / August 20, 2024 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, announced today that the Company is voluntarily delisting...
CB Scientific, Inc. Concludes its Annual Meeting of Stockholders
Shareholders endorse name change to Cardiac Biotech Solutions, Inc. subject to regulatory approval LAS VEGAS, NV / ACCESSWIRE / March 19, 2024 / CB Scientific, Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac...
CB Scientific, Inc. 2023 Year in Review
Recap includes transformational matters affecting the Company's position to manage impending growth LAS VEGAS, NV / ACCESSWIRE / January 11, 2024 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring...
CB Scientific, Inc. (CBSC) Announces the Engagement of MaloneBailey, LLP
CBSC begins independent Financial Audit through MaloneBailey, LLP. ESCONDIDO, CA / ACCESSWIRE / October 5, 2021 / CB Scientific.
CB Scientific, Inc. (CBSC) Announces the Launch of Direct-to-Consumer Heart Wellness Check-Up Program in Bangkok, Thailand
Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd.
CB Scientific, Inc. (CBSC) enters into a Consultant Services Agreement with the Dorchester Group LLC
ESCONDIDO, CA/ ACCESSWIRE/ September 23, 2021 / CB Scientific. Inc. ( OTC PINK:CBSC ) ("CBSC" or the "Company"), a provider of remote cardiac monitoring products and services (my-Cam™ monitor and my-Cardia™ cloud-based software portal), both domestically and internationally, today announced...
CB Scientific, Inc. (CBSC) Distributor Mango Wellness Comes to an Agreement to Provide Services to Three Major Hospital Chains in Thailand
Successful introductory product trials result in an agreement by three major hospital chains to use the my-Cam device ESCONDIDO, CA / ACCESSWIRE / March 16, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a provider of innovative...
CB Scientific, Inc. Announces Appointment of New Director for Asia Pacific
CBSC has appointed Jeslie Chui as Director of Business Development Asia PacificEscondido, California--(Newsfile Corp. - March 2, 2021) - CB Scientific. Inc. (OTC Pink: CBSC) ("CBSC" or the "Company"), in an ongoing effort to expand its outreach in the Ambulatory...
Source: https://incomestatements.info
Category: Stock Reports